260 related articles for article (PubMed ID: 30721454)
21. A case of endocapillary proliferative glomerulonephritis with macrophages phagocytosing monoclonal immunoglobulin lambda light chain.
Watanabe H; Osawa Y; Goto S; Habuka M; Imai N; Ito Y; Hirose T; Chou T; Ohashi R; Shimizu A; Ehara T; Shimotori T; Narita I
Pathol Int; 2015 Jan; 65(1):38-42. PubMed ID: 25410550
[TBL] [Abstract][Full Text] [Related]
22. Multiple myeloma with crystal-storing histiocytosis, crystalline podocytopathy, and light chain proximal tubulopathy, revealed by retinal abnormalities: A case report.
Boudhabhay I; Titah C; Talbot A; Harel S; Verine J; Touchard G; Kaaki S; Gabison E; Vasseur V; Mauget-Faÿsse M; Sené T
Medicine (Baltimore); 2018 Dec; 97(52):e13638. PubMed ID: 30593133
[TBL] [Abstract][Full Text] [Related]
23. Megalosplenia as an initial manifestation of multiple myeloma with a novel CYLD gene mutation: A case report and literature review.
Zhang J; Zhang R
Medicine (Baltimore); 2024 Apr; 103(14):e37624. PubMed ID: 38579060
[TBL] [Abstract][Full Text] [Related]
24. Combined crystal-storing histiocytosis, light chain proximal tubulopathy, and light chain crystalline podocytopathy in a patient with multiple myeloma: a case report and literature review.
Zhu L; Wang L; Shi H; Jiang L; Li X; Shao C; Yan Y; Dong B; Zou W; Zuo L
Ren Fail; 2023 Dec; 45(1):2145970. PubMed ID: 36632756
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy.
Scott GB; Carter C; Parrish C; Wood PM; Cook G
Cell Immunol; 2015 Sep; 297(1):1-9. PubMed ID: 26051632
[TBL] [Abstract][Full Text] [Related]
26. Multiple myeloma presenting as cutaneous leukocytoclastic vasculitis and eosinophilia disclosing a T helper type 1/T helper type 2 imbalance: a case report.
Oka S; Ono K; Nohgawa M
J Med Case Rep; 2018 Oct; 12(1):320. PubMed ID: 30376895
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous tubular and glomerular involvement with cryoglobulinemia vasculitis in multiple myeloma.
Zahir Z; Agrawal V; Wani AS; Prasad N
Saudi J Kidney Dis Transpl; 2019; 30(6):1470-1474. PubMed ID: 31929299
[TBL] [Abstract][Full Text] [Related]
28. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
Bianchi G; Richardson PG; Anderson KC
J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
[TBL] [Abstract][Full Text] [Related]
29. Combined light chain crystalline tubulopathy, podocytopathy, and histiocytosis associated with Bence-Jones κ protein diagnosed via immuno-electron microscopy.
Nakamura Y; Kitamura H; Ikai H; Yamamoto M; Murai Y; Watanabe T; Takizawa N; Yokoyama-Kokuryo W; Ehara T; Watarai M; Shimizu H; Fujita Y
CEN Case Rep; 2021 Aug; 10(3):453-458. PubMed ID: 33675012
[TBL] [Abstract][Full Text] [Related]
30. [Complete remission achieved in a multiple myeloma patient with elevated serum KL-6 level by a combination regimen with bortezomib, cyclophosphamide, and dexamethasone].
Okuno Y; Nishimura N; Nosaka K; Hata H; Mitsuya H
Rinsho Ketsueki; 2014 Apr; 55(4):461-5. PubMed ID: 24850459
[TBL] [Abstract][Full Text] [Related]
31. A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus - clinical significance and possible mechanisms: a case report.
Takemori N; Imai G; Hoshino K; Ooi A; Kojima M
J Med Case Rep; 2018 Feb; 12(1):40. PubMed ID: 29454372
[TBL] [Abstract][Full Text] [Related]
32. Elotuzumab in Combination with Lenalidomide and Dexamethasone for Treatment-resistant Immunoglobulin Light Chain Amyloidosis With Multiple Myeloma.
Iqbal SM; Stecklein K; Sarow J; Krabak M; Hillengass J; McCarthy P
Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):e33-e36. PubMed ID: 30337238
[No Abstract] [Full Text] [Related]
33. Successful Treatment of Amyloid Light-chain Amyloidosis in a Charcot-Marie-Tooth Disease Patient with Lenalidomide, Cyclophosphamide, and Dexamethasone.
Kikukawa Y; Hata H; Ueda M; Yamashita T; Nasu S; Ide K; Ueno S; Ando Y; Mitsuya H; Okuno Y
Intern Med; 2016; 55(18):2707-12. PubMed ID: 27629972
[TBL] [Abstract][Full Text] [Related]
34. [Biclonal light chain gammopathy in multiple myeloma--a case report].
Ogasawara T; Yasuyama M; Kawauchi K
Nihon Rinsho Meneki Gakkai Kaishi; 2002 Apr; 25(2):170-6. PubMed ID: 12043184
[TBL] [Abstract][Full Text] [Related]
35. [Achievement of hemodialysis discontinuation with lenalidomide and dexamethasone therapy in a refractory BJP-type multiple myeloma patient].
Uchida T; Inoue M; Hua J; Hagihara M
Rinsho Ketsueki; 2016 May; 57(5):613-7. PubMed ID: 27263787
[TBL] [Abstract][Full Text] [Related]
36. [Multiple myeloma developing in a patient with immune thrombocytopenia].
Itoh T
Rinsho Ketsueki; 2016 May; 57(5):630-3. PubMed ID: 27263790
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review.
Yu XJ; Zhou XJ; Wang SX; Zhou FD; Zhao MH
BMC Nephrol; 2018 Nov; 19(1):322. PubMed ID: 30419839
[TBL] [Abstract][Full Text] [Related]
38. lenalidomide (REVLIMID°) in untreated multiple myeloma.
Prescrire Int; 2016 Nov; 25(176):263-264. PubMed ID: 30715822
[TBL] [Abstract][Full Text] [Related]
39. [Secondary monoclonal gammopathy after bone marrow autotransplantation as a cause of worse renal function in light chain immunoglobulin deposition disease].
Rekhtina IG; Mendeleeva LP; Stolyarevich ES; Galtseva IV; Povilaitite PE; Biryukova LS
Ter Arkh; 2016; 88(6):80-83. PubMed ID: 27296267
[TBL] [Abstract][Full Text] [Related]
40. Adult Fanconi syndrome secondary to kappa-light chain myeloma: improvement of tubular functions after treatment for myeloma.
Uchida S; Matsuda O; Yokota T; Takemura T; Ando R; Kanemitsu H; Hamaguchi H; Miyake S; Marumo F
Nephron; 1990; 55(3):332-5. PubMed ID: 2115147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
